Generate a tailored SOP for Dr. Eric Winer. Improve your application with a focused, well-structured draft.
Dr. Eric Winer is an internationally renowned expert in breast cancer and serves as the Alfred Gilman Professor of Medicine and Pharmacology at Yale School of Medicine. He was appointed Director of the Yale Cancer Center and President Physician-in-Chief of Smilow Cancer Hospital on February 1, 2022. Over his career, Dr. Winer has led numerous clinical trials that have significantly influenced the understanding and treatment of breast cancer, especially in HER2-positive diseases. He advocates for collaborative teams of scientists and clinicians to accelerate progress in cancer research and care. Dr. Winer has published over 600 articles and has mentored 30 fellows and junior faculty. His contributions to the field have earned him numerous awards, including the William Silen Lifetime Achievement Mentoring Award from Harvard Medical School in 2020 and several accolades related to his research in breast cancer. Dr. Winer previously served as the chief scientific advisor for Susan G. Komen for the Cure and held the position of chief clinical development officer at Dana-Farber Cancer Institute. He continues to drive research and clinical advancements in breast oncology, passionate about improving patient care and outcomes.
Yale Cancer Center • New Haven, CT
Appointed as the Director of Yale Cancer Center.
Smilow Cancer Hospital • New Haven, CT
Serves as President Physician-in-Chief at Smilow Cancer Hospital.
Yale School of Medicine • New Haven, CT
Deputy Dean focusing on Cancer Research at Yale School of Medicine.
Dana-Farber Cancer Institute • Boston, MA
Served as Chief Clinical Development Officer leading cancer research advancements.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.